The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Next-Generation Antibody Drug Market Research Report 2025
Synopsis
The global Next-Generation Antibody Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Next-Generation Antibody Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next-Generation Antibody Drug.
Report Scope
The Next-Generation Antibody Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next-Generation Antibody Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next-Generation Antibody Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Amgen
Janssen
Sanofi
Pfizer
Johnson & Johnson
AstraZeneca
AbbVie
Lindis Biotech
MacroGenics, Inc
Genmab
Alphamab Oncology
Akeso
Innovent Biologics
Yzy Medical Science & Technology
Segment by Type
Fragment-Based
IgG-Based
Segment by Application
Cancer
Hemophilia
Other Diseases
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Next-Generation Antibody Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Next-Generation Antibody Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Next-Generation Antibody Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Next-Generation Antibody Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next-Generation Antibody Drug.
Report Scope
The Next-Generation Antibody Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next-Generation Antibody Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next-Generation Antibody Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Amgen
Janssen
Sanofi
Pfizer
Johnson & Johnson
AstraZeneca
AbbVie
Lindis Biotech
MacroGenics, Inc
Genmab
Alphamab Oncology
Akeso
Innovent Biologics
Yzy Medical Science & Technology
Segment by Type
Fragment-Based
IgG-Based
Segment by Application
Cancer
Hemophilia
Other Diseases
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Next-Generation Antibody Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Next-Generation Antibody Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Next-Generation Antibody Drug Market Overview
1.1 Product Overview and Scope of Next-Generation Antibody Drug
1.2 Next-Generation Antibody Drug Segment by Type
1.2.1 Global Next-Generation Antibody Drug Market Value Comparison by Type (2024-2030)
1.2.2 Fragment-Based
1.2.3 IgG-Based
1.3 Next-Generation Antibody Drug Segment by Application
1.3.1 Global Next-Generation Antibody Drug Market Value by Application: (2024-2030)
1.3.2 Cancer
1.3.3 Hemophilia
1.3.4 Other Diseases
1.4 Global Next-Generation Antibody Drug Market Size Estimates and Forecasts
1.4.1 Global Next-Generation Antibody Drug Revenue 2019-2030
1.4.2 Global Next-Generation Antibody Drug Sales 2019-2030
1.4.3 Global Next-Generation Antibody Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Next-Generation Antibody Drug Market Competition by Manufacturers
2.1 Global Next-Generation Antibody Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Next-Generation Antibody Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Next-Generation Antibody Drug Average Price by Manufacturers (2019-2024)
2.4 Global Next-Generation Antibody Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Next-Generation Antibody Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Next-Generation Antibody Drug, Product Type & Application
2.7 Next-Generation Antibody Drug Market Competitive Situation and Trends
2.7.1 Next-Generation Antibody Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Next-Generation Antibody Drug Players Market Share by Revenue
2.7.3 Global Next-Generation Antibody Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Next-Generation Antibody Drug Retrospective Market Scenario by Region
3.1 Global Next-Generation Antibody Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Next-Generation Antibody Drug Global Next-Generation Antibody Drug Sales by Region: 2019-2030
3.2.1 Global Next-Generation Antibody Drug Sales by Region: 2019-2024
3.2.2 Global Next-Generation Antibody Drug Sales by Region: 2025-2030
3.3 Global Next-Generation Antibody Drug Global Next-Generation Antibody Drug Revenue by Region: 2019-2030
3.3.1 Global Next-Generation Antibody Drug Revenue by Region: 2019-2024
3.3.2 Global Next-Generation Antibody Drug Revenue by Region: 2025-2030
3.4 North America Next-Generation Antibody Drug Market Facts & Figures by Country
3.4.1 North America Next-Generation Antibody Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Next-Generation Antibody Drug Sales by Country (2019-2030)
3.4.3 North America Next-Generation Antibody Drug Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Next-Generation Antibody Drug Market Facts & Figures by Country
3.5.1 Europe Next-Generation Antibody Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Next-Generation Antibody Drug Sales by Country (2019-2030)
3.5.3 Europe Next-Generation Antibody Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Next-Generation Antibody Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Next-Generation Antibody Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Next-Generation Antibody Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Next-Generation Antibody Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Next-Generation Antibody Drug Market Facts & Figures by Country
3.7.1 Latin America Next-Generation Antibody Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Next-Generation Antibody Drug Sales by Country (2019-2030)
3.7.3 Latin America Next-Generation Antibody Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Next-Generation Antibody Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Next-Generation Antibody Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Next-Generation Antibody Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Next-Generation Antibody Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Next-Generation Antibody Drug Sales by Type (2019-2030)
4.1.1 Global Next-Generation Antibody Drug Sales by Type (2019-2024)
4.1.2 Global Next-Generation Antibody Drug Sales by Type (2025-2030)
4.1.3 Global Next-Generation Antibody Drug Sales Market Share by Type (2019-2030)
4.2 Global Next-Generation Antibody Drug Revenue by Type (2019-2030)
4.2.1 Global Next-Generation Antibody Drug Revenue by Type (2019-2024)
4.2.2 Global Next-Generation Antibody Drug Revenue by Type (2025-2030)
4.2.3 Global Next-Generation Antibody Drug Revenue Market Share by Type (2019-2030)
4.3 Global Next-Generation Antibody Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Next-Generation Antibody Drug Sales by Application (2019-2030)
5.1.1 Global Next-Generation Antibody Drug Sales by Application (2019-2024)
5.1.2 Global Next-Generation Antibody Drug Sales by Application (2025-2030)
5.1.3 Global Next-Generation Antibody Drug Sales Market Share by Application (2019-2030)
5.2 Global Next-Generation Antibody Drug Revenue by Application (2019-2030)
5.2.1 Global Next-Generation Antibody Drug Revenue by Application (2019-2024)
5.2.2 Global Next-Generation Antibody Drug Revenue by Application (2025-2030)
5.2.3 Global Next-Generation Antibody Drug Revenue Market Share by Application (2019-2030)
5.3 Global Next-Generation Antibody Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Next-Generation Antibody Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Next-Generation Antibody Drug Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Next-Generation Antibody Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Amgen Next-Generation Antibody Drug Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Janssen
6.3.1 Janssen Corporation Information
6.3.2 Janssen Description and Business Overview
6.3.3 Janssen Next-Generation Antibody Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Janssen Next-Generation Antibody Drug Product Portfolio
6.3.5 Janssen Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Next-Generation Antibody Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Next-Generation Antibody Drug Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Next-Generation Antibody Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Next-Generation Antibody Drug Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Next-Generation Antibody Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Johnson & Johnson Next-Generation Antibody Drug Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Next-Generation Antibody Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AstraZeneca Next-Generation Antibody Drug Product Portfolio
6.7.5 AstraZeneca Recent Developments/Updates
6.8 AbbVie
6.8.1 AbbVie Corporation Information
6.8.2 AbbVie Description and Business Overview
6.8.3 AbbVie Next-Generation Antibody Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 AbbVie Next-Generation Antibody Drug Product Portfolio
6.8.5 AbbVie Recent Developments/Updates
6.9 Lindis Biotech
6.9.1 Lindis Biotech Corporation Information
6.9.2 Lindis Biotech Description and Business Overview
6.9.3 Lindis Biotech Next-Generation Antibody Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Lindis Biotech Next-Generation Antibody Drug Product Portfolio
6.9.5 Lindis Biotech Recent Developments/Updates
6.10 MacroGenics, Inc
6.10.1 MacroGenics, Inc Corporation Information
6.10.2 MacroGenics, Inc Description and Business Overview
6.10.3 MacroGenics, Inc Next-Generation Antibody Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 MacroGenics, Inc Next-Generation Antibody Drug Product Portfolio
6.10.5 MacroGenics, Inc Recent Developments/Updates
6.11 Genmab
6.11.1 Genmab Corporation Information
6.11.2 Genmab Next-Generation Antibody Drug Description and Business Overview
6.11.3 Genmab Next-Generation Antibody Drug Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Genmab Next-Generation Antibody Drug Product Portfolio
6.11.5 Genmab Recent Developments/Updates
6.12 Alphamab Oncology
6.12.1 Alphamab Oncology Corporation Information
6.12.2 Alphamab Oncology Next-Generation Antibody Drug Description and Business Overview
6.12.3 Alphamab Oncology Next-Generation Antibody Drug Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Alphamab Oncology Next-Generation Antibody Drug Product Portfolio
6.12.5 Alphamab Oncology Recent Developments/Updates
6.13 Akeso
6.13.1 Akeso Corporation Information
6.13.2 Akeso Next-Generation Antibody Drug Description and Business Overview
6.13.3 Akeso Next-Generation Antibody Drug Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Akeso Next-Generation Antibody Drug Product Portfolio
6.13.5 Akeso Recent Developments/Updates
6.14 Innovent Biologics
6.14.1 Innovent Biologics Corporation Information
6.14.2 Innovent Biologics Next-Generation Antibody Drug Description and Business Overview
6.14.3 Innovent Biologics Next-Generation Antibody Drug Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Innovent Biologics Next-Generation Antibody Drug Product Portfolio
6.14.5 Innovent Biologics Recent Developments/Updates
6.15 Yzy Medical Science & Technology
6.15.1 Yzy Medical Science & Technology Corporation Information
6.15.2 Yzy Medical Science & Technology Next-Generation Antibody Drug Description and Business Overview
6.15.3 Yzy Medical Science & Technology Next-Generation Antibody Drug Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Yzy Medical Science & Technology Next-Generation Antibody Drug Product Portfolio
6.15.5 Yzy Medical Science & Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Next-Generation Antibody Drug Industry Chain Analysis
7.2 Next-Generation Antibody Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Next-Generation Antibody Drug Production Mode & Process
7.4 Next-Generation Antibody Drug Sales and Marketing
7.4.1 Next-Generation Antibody Drug Sales Channels
7.4.2 Next-Generation Antibody Drug Distributors
7.5 Next-Generation Antibody Drug Customers
8 Next-Generation Antibody Drug Market Dynamics
8.1 Next-Generation Antibody Drug Industry Trends
8.2 Next-Generation Antibody Drug Market Drivers
8.3 Next-Generation Antibody Drug Market Challenges
8.4 Next-Generation Antibody Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Next-Generation Antibody Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Next-Generation Antibody Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Next-Generation Antibody Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Next-Generation Antibody Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Next-Generation Antibody Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Next-Generation Antibody Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Next-Generation Antibody Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Next-Generation Antibody Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Next-Generation Antibody Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Next-Generation Antibody Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Next-Generation Antibody Drug, Product Type & Application
Table 12. Global Key Manufacturers of Next-Generation Antibody Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Next-Generation Antibody Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next-Generation Antibody Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Next-Generation Antibody Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Next-Generation Antibody Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Next-Generation Antibody Drug Sales Market Share by Region (2019-2024)
Table 19. Global Next-Generation Antibody Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Next-Generation Antibody Drug Sales Market Share by Region (2025-2030)
Table 21. Global Next-Generation Antibody Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Next-Generation Antibody Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Next-Generation Antibody Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Next-Generation Antibody Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Next-Generation Antibody Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Next-Generation Antibody Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Next-Generation Antibody Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Next-Generation Antibody Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Next-Generation Antibody Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Next-Generation Antibody Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Next-Generation Antibody Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Next-Generation Antibody Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Next-Generation Antibody Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Next-Generation Antibody Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Next-Generation Antibody Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Next-Generation Antibody Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Next-Generation Antibody Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Next-Generation Antibody Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Next-Generation Antibody Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Next-Generation Antibody Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Next-Generation Antibody Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Next-Generation Antibody Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Next-Generation Antibody Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Next-Generation Antibody Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Next-Generation Antibody Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Next-Generation Antibody Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Next-Generation Antibody Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Next-Generation Antibody Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Next-Generation Antibody Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Next-Generation Antibody Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Next-Generation Antibody Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Next-Generation Antibody Drug Sales Market Share by Type (2019-2024)
Table 53. Global Next-Generation Antibody Drug Sales Market Share by Type (2025-2030)
Table 54. Global Next-Generation Antibody Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Next-Generation Antibody Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Next-Generation Antibody Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Next-Generation Antibody Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Next-Generation Antibody Drug Price (US$/Unit) by Type (2019-2024)
Table 59. Global Next-Generation Antibody Drug Price (US$/Unit) by Type (2025-2030)
Table 60. Global Next-Generation Antibody Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Next-Generation Antibody Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Next-Generation Antibody Drug Sales Market Share by Application (2019-2024)
Table 63. Global Next-Generation Antibody Drug Sales Market Share by Application (2025-2030)
Table 64. Global Next-Generation Antibody Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Next-Generation Antibody Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Next-Generation Antibody Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Next-Generation Antibody Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Next-Generation Antibody Drug Price (US$/Unit) by Application (2019-2024)
Table 69. Global Next-Generation Antibody Drug Price (US$/Unit) by Application (2025-2030)
Table 70. Roche Corporation Information
Table 71. Roche Description and Business Overview
Table 72. Roche Next-Generation Antibody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Roche Next-Generation Antibody Drug Product
Table 74. Roche Recent Developments/Updates
Table 75. Amgen Corporation Information
Table 76. Amgen Description and Business Overview
Table 77. Amgen Next-Generation Antibody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Amgen Next-Generation Antibody Drug Product
Table 79. Amgen Recent Developments/Updates
Table 80. Janssen Corporation Information
Table 81. Janssen Description and Business Overview
Table 82. Janssen Next-Generation Antibody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Janssen Next-Generation Antibody Drug Product
Table 84. Janssen Recent Developments/Updates
Table 85. Sanofi Corporation Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi Next-Generation Antibody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Sanofi Next-Generation Antibody Drug Product
Table 89. Sanofi Recent Developments/Updates
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Next-Generation Antibody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Pfizer Next-Generation Antibody Drug Product
Table 94. Pfizer Recent Developments/Updates
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Next-Generation Antibody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Johnson & Johnson Next-Generation Antibody Drug Product
Table 99. Johnson & Johnson Recent Developments/Updates
Table 100. AstraZeneca Corporation Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca Next-Generation Antibody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. AstraZeneca Next-Generation Antibody Drug Product
Table 104. AstraZeneca Recent Developments/Updates
Table 105. AbbVie Corporation Information
Table 106. AbbVie Description and Business Overview
Table 107. AbbVie Next-Generation Antibody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. AbbVie Next-Generation Antibody Drug Product
Table 109. AbbVie Recent Developments/Updates
Table 110. Lindis Biotech Corporation Information
Table 111. Lindis Biotech Description and Business Overview
Table 112. Lindis Biotech Next-Generation Antibody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Lindis Biotech Next-Generation Antibody Drug Product
Table 114. Lindis Biotech Recent Developments/Updates
Table 115. MacroGenics, Inc Corporation Information
Table 116. MacroGenics, Inc Description and Business Overview
Table 117. MacroGenics, Inc Next-Generation Antibody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. MacroGenics, Inc Next-Generation Antibody Drug Product
Table 119. MacroGenics, Inc Recent Developments/Updates
Table 120. Genmab Corporation Information
Table 121. Genmab Description and Business Overview
Table 122. Genmab Next-Generation Antibody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Genmab Next-Generation Antibody Drug Product
Table 124. Genmab Recent Developments/Updates
Table 125. Alphamab Oncology Corporation Information
Table 126. Alphamab Oncology Description and Business Overview
Table 127. Alphamab Oncology Next-Generation Antibody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Alphamab Oncology Next-Generation Antibody Drug Product
Table 129. Alphamab Oncology Recent Developments/Updates
Table 130. Akeso Corporation Information
Table 131. Akeso Description and Business Overview
Table 132. Akeso Next-Generation Antibody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Akeso Next-Generation Antibody Drug Product
Table 134. Akeso Recent Developments/Updates
Table 135. Innovent Biologics Corporation Information
Table 136. Innovent Biologics Description and Business Overview
Table 137. Innovent Biologics Next-Generation Antibody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Innovent Biologics Next-Generation Antibody Drug Product
Table 139. Innovent Biologics Recent Developments/Updates
Table 140. Yzy Medical Science & Technology Corporation Information
Table 141. Yzy Medical Science & Technology Description and Business Overview
Table 142. Yzy Medical Science & Technology Next-Generation Antibody Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Yzy Medical Science & Technology Next-Generation Antibody Drug Product
Table 144. Yzy Medical Science & Technology Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Next-Generation Antibody Drug Distributors List
Table 148. Next-Generation Antibody Drug Customers List
Table 149. Next-Generation Antibody Drug Market Trends
Table 150. Next-Generation Antibody Drug Market Drivers
Table 151. Next-Generation Antibody Drug Market Challenges
Table 152. Next-Generation Antibody Drug Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Next-Generation Antibody Drug
Figure 2. Global Next-Generation Antibody Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Next-Generation Antibody Drug Market Share by Type in 2023 & 2030
Figure 4. Fragment-Based Product Picture
Figure 5. IgG-Based Product Picture
Figure 6. Global Next-Generation Antibody Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Next-Generation Antibody Drug Market Share by Application in 2023 & 2030
Figure 8. Cancer
Figure 9. Hemophilia
Figure 10. Other Diseases
Figure 11. Global Next-Generation Antibody Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Next-Generation Antibody Drug Market Size (2019-2030) & (US$ Million)
Figure 13. Global Next-Generation Antibody Drug Sales (2019-2030) & (K Units)
Figure 14. Global Next-Generation Antibody Drug Average Price (US$/Unit) & (2019-2030)
Figure 15. Next-Generation Antibody Drug Report Years Considered
Figure 16. Next-Generation Antibody Drug Sales Share by Manufacturers in 2023
Figure 17. Global Next-Generation Antibody Drug Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Next-Generation Antibody Drug Players: Market Share by Revenue in 2023
Figure 19. Next-Generation Antibody Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Next-Generation Antibody Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Next-Generation Antibody Drug Sales Market Share by Country (2019-2030)
Figure 22. North America Next-Generation Antibody Drug Revenue Market Share by Country (2019-2030)
Figure 23. United States Next-Generation Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Next-Generation Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Next-Generation Antibody Drug Sales Market Share by Country (2019-2030)
Figure 26. Europe Next-Generation Antibody Drug Revenue Market Share by Country (2019-2030)
Figure 27. Germany Next-Generation Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Next-Generation Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Next-Generation Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Next-Generation Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Next-Generation Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Next-Generation Antibody Drug Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Next-Generation Antibody Drug Revenue Market Share by Region (2019-2030)
Figure 34. China Next-Generation Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Next-Generation Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Next-Generation Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Next-Generation Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Next-Generation Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Next-Generation Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Next-Generation Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Next-Generation Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Next-Generation Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Next-Generation Antibody Drug Sales Market Share by Country (2019-2030)
Figure 44. Latin America Next-Generation Antibody Drug Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Next-Generation Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Next-Generation Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Next-Generation Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Next-Generation Antibody Drug Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Next-Generation Antibody Drug Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Next-Generation Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Next-Generation Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Next-Generation Antibody Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Next-Generation Antibody Drug by Type (2019-2030)
Figure 54. Global Revenue Market Share of Next-Generation Antibody Drug by Type (2019-2030)
Figure 55. Global Next-Generation Antibody Drug Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Next-Generation Antibody Drug by Application (2019-2030)
Figure 57. Global Revenue Market Share of Next-Generation Antibody Drug by Application (2019-2030)
Figure 58. Global Next-Generation Antibody Drug Price (US$/Unit) by Application (2019-2030)
Figure 59. Next-Generation Antibody Drug Value Chain
Figure 60. Next-Generation Antibody Drug Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
